Summary:
Early phase study looking to see how the body excretes a single dose of study medication in people with various stages of kidney disease. You will be monitored while you stay over at our facility for approximately 6 days/5 nights.
Criteria:Have a diagnosis of Chronic Kidney Disease (CKD) stage 1, 2, 3 or higher, or have a lab value of eGFR (glomerular filtration rate) of less than 90 or creatinine higher than normal.
Qualified Participants May Receive:
Compensation for their time and travel of $2,800.